| |
[Tyr 8]-Bradykinin  |
|
|
| Cat. No. |
Size |
Price |
Figures |
|---|
RP11151-5 mg
| 5 mg | $ 33.25 | MSDS: 20080702040347 (PDF)
References:
- Wang H, et al. Bradykinin produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic transmission. J. Neurosci. Aug 2005; 25(35): 7986-7992.
- Leeb-Lundberg LM, et al. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. Mar 2005; 57(1): 27-77.
- Stuardo M, et al. Stimulated human neutrophils form biologically active kinin peptides from high and low molecular weight kininogens. J. Leukoc. Biol. Apr 2004; 75(4): 631-640.
|
|---|
| Full Name | |
| Alias |
[Tyr8] BK |
Sequence
(one-letter code) |
RPPGFSPYR | Sequence
(three-letter code) | {ARG}{PRO}{PRO}{GLY}{PHE}{SER}{PRO}{TYR}{ARG} |
|---|
| Description | [Tyr8] Bradykinin is useful for determination of human urinary kinin levels. The N-terminal amino group of [Tyr8]bradykinin is bound to analogous positions of the rat and of the human B2 receptor, [Tyr8]bradykinin's N terminus is bound adjacent to Lys172 of the human and Lys174 of the rat B2 receptor. |
|---|
| Formula | C50H73N15O12 |
|---|
| M.W. | 1076.21 |
|---|
| Cas | 32222-00-7 |
|---|
| Purity | > 95% |
|---|
| Storage | Store at -20°C |
|
